Publications | Lieberman Lab

2026

Yisimayi A, Zhang H, Lieberman J. SARS-CoV-2 mRNA vaccination sensitizes tumors to immune checkpoint blockade. Vita. 2026 Jan 22.

Zhang Z, Lieberman J. Pyroptosis: Turning Up the Heat on Cancer. Annu Rev Immunol. 2026 Apr;44(1):295-323.

Yisimayi A, Lieberman J. A cell-death protein has an unexpected role in intestinal repair. Nature. 2026 Apr;652(8112):1135-1137.

Barbosa CRR, de Lacerda LB, Bettencourt PJG, Morrow D, Pereira DB, Aleshnick M, Mitchell JL, Poulton NC, Gomes C, Cordeiro LPB, Doumbia K, Ntalla C, Arama C, Zhao Z, Maia GC, Almeida GG, Schrimpf MR, Hart TF, Haumpy D, Medeiros-Rodrigues BC, Costa CM, Nicastri A, Gilbride RM, Schell JB, Kirtley P, Antonelli LRV, Gaiha GD, Hansen SG, Lieberman J, Gazzinelli RT, Niangaly M, Woodford J, Goldberg J, Früh K, Portugal S, Duffy PE, Ternette N, Wilder B, Hill AVS, Junqueira C. Identification of cross-stage, cross-species malaria CD8+ T cell antigens. Nature. 2026 Jul;655(8123):747-757 .

Dixon SJ, Kroemer G, Lessene G, Lieberman J, Silke J. Emerging challenges, mechanisms, and therapeutic opportunities in cell death. 2026 Jul;33:889–891.Cell Chem Biol.

Du G, Ehrmann J.F., Lieberman J, and Wu H. Structural basis of GSDME pore formation and its regulation by S-palmitoylation. PNAS. 2026 Aug 24. 123(35), p.e2614339123.

2025

Gu B, Ferreira LMR, Herrera S, Brown L, Lieberman J, Sherwood RI, Meissner TB, Strominger JL. The TEA domain transcription factors TEAD1 and TEAD3 and WNT signaling determine HLA-G expression in human extravillous trophoblasts. PNAS. 2025 Mar 25;122(12):e2425339122.

Elkayam E, Gervais FG, Wu H, Crackower MA, Lieberman J. New insights into the noncanonical inflammasome point to caspase-4 as a druggable target. Nat Rev Immunol. 2025 Mar 5.

Faust Akl C, Andersen BM, Li Z, Giovannoni F, Diebold M, Sanmarco LM, Kilian M, Fehrenbacher L, Pernin F, Rone JM, Lee HG, Piester G, Kenison JE, Lee JH, Illouz T, Polonio CM, Srun L, Martinez J, Chung EN, Schüle A, Plasencia A, Li L, Ferrara K, Lewandrowski M, Strathdee CA, Lerner L, Quéva C, Clark IC, Deneen B, Lieberman J, Sherr DH, Antel JP, Wheeler MA, Ligon KL, Chiocca EA, Prinz M, Reardon DA, Quintana FJ. Glioblastoma-instructed astrocytes suppress tumour-specific T cell immunity. Nature. 2025 Jul;643(8070):219-229.

Bai Y, Zhang C, Liu H, Deng F, Wu Z, Deng W, Zheng Z, Min R, Mei S, Kang H, Yu H, Pan Y, Lieberman J, Zhao J, Liu X. ER-resident CCDC134 safeguards TLR4 maturation by maintaining gp96 stability. PNAS. 2025 Aug 26;122(34):e2512154122.

Zhang Z, Zhang Y, Lieberman J. Innate immunity in tumour immunoediting and immunosurveillance. EMBO J. 2025 Nov 28.

2024

Fontana P, Du G, Zhang Y, Zhang H, Vora SM, Hu JJ, Shi M, Tufan AB, Healy LB, Xia S, Lee DJ, Li Z, Baldominos P, Ru H, Luo HR, Agudo J, Lieberman J, Wu H. Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity. Cell. 2024 Oct 31;187(22):6165-6181.e22.

Zhang Y, Naderi Yeganeh P, Zhang H, Wang SY, Li Z, Gu B, Lee DJ, Zhang Z, Ploumakis A, Shi M, Wu H, Greer EL, Hide W, Lieberman J. Tumor editing suppresses innate and adaptive antitumor immunity and is reversed by inhibiting DNA methylation. Nat Immunol. 2024 Oct;25(10):1858-1870.

Liu X, Lieberman J. Inflammasome-independent pyroptosis. Curr Opin Immunol. 2024 Jun;88:102432.

Ma X, Lieberman J. Poking holes in the blood-brain barrier. Immunity. 2024 Jun 11;57(6):1192-1194.

Du G, Healy LB, David L, Walker C, El-Baba TJ, Lutomski CA, Goh B, Gu B, Pi X, Devant P, Fontana P, Dong Y, Ma X, Miao R, Balasubramanian A, Puthenveetil R, Banerjee A, Luo HR, Kagan JC, Oh SF, Robinson CV, Lieberman J, Wu H. ROS-dependent S-palmitoylation activates cleaved and intact gasdermin D. Nature. 2024 Jun;630(8016):437-446.

Balasubramanian A, Hsu AY, Ghimire L, Tahir M, Devant P, Fontana P, Du G, Liu X, Fabin D, Kambara H, Xie X, Liu F, Hasegawa T, Xu R, Yu H, Chen M, Kolakowski S, Trauger S, Larsen MR, Wei W, Wu H, Kagan JC, Lieberman J, Luo HR. The palmitoylation of gasdermin D directs its membrane translocation and pore formation during pyroptosis. Sci Immunol. 2024 Apr 12;9(94):eadn1452.

Zhang Z, Lieberman J. MALAT1 protects dormant tumor cells from immune elimination. Nat Cancer. 2024 Feb;5(2):218-220.

Kotzur R, Kahlon S, Isaacson B, Gamliel M, Charpak-Amikam Y, Lieberman J, Bachrach G, Goldman-Wohl D, Yagel S, Beharier O, Mandelboim O. Pregnancy trained decidual NK cells protect pregnancies from harmful Fusobacterium nucleatum infection. PLoS Pathog. 2024 Jan 12;20(1):e1011923.

2023

Miao R, Jiang C, Chang WY, Zhang H, An J, Ho F, Chen P, Zhang H, Junqueira C, Amgalan D, Liang FG, Zhang J, Evavold CL, Hafner-Bratkovič I, Zhang Z, Fontana P, Xia S, Waldeck-Weiermair M, Pan Y, Michel T, Bar-Peled L, Wu H, Kagan JC, Kitsis RN, Zhang P, Liu X, Lieberman J. Gasdermin D permeabilization of mitochondrial inner and outer membranes accelerates and enhances pyroptosis. Immunity. 2023 Nov 14;56(11):2523-2541.e8.

Bai Y, Min R, Chen P, Mei S, Deng F, Zheng Z, Jiang C, Miao R, Wu Z, Zhang P, Pan Y, Lieberman J, Liu X. Disulfiram blocks inflammatory TLR4 signaling by targeting MD-2. PNAS. 2023 Aug;120(31):e2306399120.

Nziza N, Tran TM, DeRiso EA, Dolatshahi S, Herman JD, de Lacerda L, Junqueira C, LIEBERMAN J, Ongoiba A, Doumbo S, Kayentao K, Traore B, Crompton PD and Alter G. Accumulation of neutrophil-phagocytic activity features tracks with naturally acquired immunity against malaria in children. J Infect Dis. 2023 Sep 15;228(6):759-768.

Kong Q, Xia S, Pan X, Ye K, Li Z, Li H, Tang X, Sahni N, Yi SS,Liu X, Wu H, Elowitz MB, LIEBERMAN J and Zhang Z. Alternate splicing of GSDMB modulates killer lymphocyte-triggered pyroptosis. Sci Immunol. 2023, 8: eadg3196.

Sumit Sen Santara, Dian-Jang Lee, Angela Crespo, Jun Jacob Hu, Caitlin Walker, Xiyu Ma, Ying Zhang, Sourav Chowdhury, Karla F. Meza-Sosa, Mercedes Lewandrowski, Haiwei Zhang, Marjorie Rowe, Arthur McClelland, Hao Wu, Caroline Junqueria and Judy Lieberman. The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells. Nature. 2023 Apr;616(7956):348-356.

Dylan V Neel, Himanish Basu, Georgia Gunner, Matthew D. Bergstresser, richard M. Giadone, Haeji Chung, Rui Miao, Vicky Chou, Eliza Brody, Xin Jang, Edward Lee, Michelle E. Watts, Christine Marques, Aaron Held, Brian Wainger, Clotilde Lagier-Tourenne, Yong-Jie Zhang, Leonard Petrucelli, Tracey Young-Pearse, Alice S. Chen-Plotkin, Lee L. Rubin, Judy Lieberman, Isaac M. Chiu. Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration. Cell Press Neuron. 2023 Apr 19;111(8):1222-1240.e9.

Changying Guo, Karla F. Meza-Sosa, David Valle-Garcia, Guomeng Zhao, Kun Gao, Liting Yu, Hongying Zhang, Yeqing Chen, Liang Sun, Shira Rockowitz, Shouyu Wang, Sheng Jiang, and Judy Lieberman. The SET oncoprotein promotes estrogen-induced transcription by facilitating establishment of active chromatin. PNAS. 2023 Feb 21;120(8):e2206878120.

Appendix

2022

Sengupta S, Das S, Crespo AC, Cornel AM, Patel AG, Mahadevan NR, Campisi M, Ali AK, Sharma B, Rowe JH, Huang h, Debruyne DN, Cerda ES, Krajewska M, Dries R, Chen M, Zhang S, Soriano L, Cohen MA, Versteeg R, Jaenisch R, Spranger S, Romee R, Miller BC, Barbie DA, Nierkens S, Dyer MA, Lieberman J and George RE. Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes. Nat Cancer. 2022 Oct;3(10):1228-1246.

Eskandari SK, Allos H, Al Dulaijan BS, Melhem G, Sulkaj I, Alhaddad JB, Saad AJ, Deban C, Chu P, Choi JY, Kollar B, Pomahac B, Riella LV, Berger, SP, Sanders JS, LIEBERMAN J, Li L and Azzi JR. mTORC inhibition protects human regulatory T cells from granzyme B-induced apoptosis. Front Immunol. 2022 Jun 10;13:899975.

Sefik E, QuR, Junqueira C, Kaffe E, Mirza H, Zhao J, Brewer JR, Han A, Steach H, Israelow B, Blackburn HN, Velazquez S, Chen YG, Halene S, Iwasaki A, Meffre E, Nussenzweig M, LIEBERMAN J, Wilen C, Kluger Y and Flavell RA. Inflammasome activation in infected macrophages drives pathology in COVID-19. Nature. 2022 Jun;606(7914):585-593.

Junqueira C, Crespo A, Ranjbar S, de Lacerda LB, Lewandrowski M, Ingber J, Parry B, Ravid S, Clark S, Schrimpf MR, Ho F, Beakes C, Margolin J, Russell N, Kays K, Boucau J, Adhikari UD, Vora SM, Leger V, Gehrke L, Henderson L, Janssen E, Kwon D, Sander C, Abraham J, Goldberg MB, Wu H, Mehta G, Bell S, Goldfeld AE, Filbin MR and LIEBERMAN J. SARS-CoV-2 infects blood monocytes via FcgR and activates inflammation. Nature. 2022 Jun;606(7914):576-584.

Vora, SM, Fontana P, Mao, T, Leger V, Zhang Y, Fu T-M, LIEBERMAN J, Gehrke L, Shi M, Wang L, Iwasaki A, and Wu H. Targeting Stem-loop 1 of the SARS-CoV-2 5’UTR to suppress viral translation and Nsp1 evasion. PNAS. 2022 Mar 1;119(9):e2117198119.

Meza-Sosa KF, Miao R, Navarro F, Zhang Z, Zhang Y, Hu JJ, Hartford CCR, Li XL, Pedraza-Alva G, Perez-Martinez L, Lal A, Wu H and LIEBERMAN J. SPARCLE, a p53-induced lncRNA, controls apoptosis after genotoxic stress by promoting PARP-1 cleavage. Mol Cell. 2022, 82:785-802.

Deng W, Bai Y, Deng F, Pan Y, Mei S, Zheng Z, Min R, Wu Z, Li W, Miao R, Zhang Z, Kupper TS, LIEBERMAN J and Liu X. The Streptococcus pyogenes virulence factor SpeB cleaves GSDMA and triggers pyroptosis. Nature. 2022, 602:496-502.

2021

Sen Santara S, Crespo AC, Mulik S, Ovies C, Boulenouar S, Strominger J and LIEBERMAN J. Decidual NK kill Zika virus-infected trophoblasts. PNAS. 2021, 118: e2115410118.

Supplementary materials

Fillmore N, Bell S, Shen C, Nguyen V, La J, Dubreuil M, Strymish J, Brophy M, Mehta G, Wu H, LIEBERMAN J, Do N and Sander C. Disulfiram use is associated with lower risk of Covid-19: a retrospective cohort study. PLoS ONE. 16: e0259061.

Supplementary Tables

Wenqing Gao, Yuanyuan Li, Xuehe Liu, Sen Wang, Pucheng Mei, Zijun Chen, Kewei Liu, Suhua Li, Xue-Wei Xu, Jianhua Gan, Jiaxue Wu, Chaoneng Ji, Chen Ding, Xing Liu, Yuping Lai, Housheng Hansen He, Judy Lieberman, Hao Wu, Xiangjun Chen, Jixi Li. TRIM21 regulates pyroptotic cell death by promoting Gasdermin D oligomerization. Cell Death & Differentiation. 2021 Sep.

Supplementary information

Wang C, Yang T, Xiao J, Xu C, Alippe Y, Sun K, Kanneganti TD, Monahan JB, Abu-Amer Y, Lieberman J, Mbalaviele G. NLRP3 inflammasome activation triggers gasdermin D-independent inflammation. Sci Immunol. 2021 Oct 22;6(64):eabj3859.

Vora SM, Lieberman J, Wu H. Inflammasome activation at the crux of severe COVID-19. Nature Reviews Immunology. 2021.

Xia S, Zhang Z, Magupalli V, Pablo J, Dong Y, Vora S, Wang L, Fu TM, Jacobson M, Greka A, Lieberman J, Ruan J, Wu H. Gasdermin D pore structure reveals preferential release of mature interleukin-1. Nature. 2021; 593:607.f

Z Zheng, W Deng, Y Bai, R Miao, S Mei, Z Zhang, Y Pan, Y Wang, R Min, et al. The lysosomal Rag-Ragulator complex licenses RIPK1–and caspase-8–mediated pyroptosis by Yersinia. Science. 2021; 372: 6549.

X Liu, S Xia, Z Zhang, H Wu, J Lieberman. Channelling inflammation: gasdermins in physiology and disease. Nature Reviews Drug Discovery. 2021; 20:384.

Junqueira C, Polidoro R, Castro G, Absalon S, Liang Z, Sen Santara S, Crespo A, Pereira DB, Dvorin JD, Lieberman J. gd T cells suppress Plasmodium falciparum blood stage infection by direct killing and phagocytosis. Nat Immunol. 2021.

Wang C, Yang T, Xiao J, Xu C, Alippe Y, Sun K, Kanneganti TD, Monahan JB, Abu-Amer Y, Lieberman J, Mbalaviele G. Activation of GSDMD compensates for GSDMD deficiency in a mouse model of NLRP3 inflammasomopathy. bioRxiv. 2021.

Z Hong, J Mei, C Li, G Bai, M Maimaiti, H Hu, W Yu, L Sun, L Zhang, et al. STING inhibitors target the cyclic dinucleotide binding pocket. PNAS. 2021; 118(24).

Supplementary material

Liu X, Xia S, Zhang Z, Wu H, Lieberman J. Channeling inflammation: Gasdermins in physiology and disease. Nat Rev Drug Discov. 2021; 20:384-405.

N Fillmore, S Bell, C Shen, V Nguyen, J La, M Dubreuil, J Strymish, et al. Disulfiram associated with lower risk of Covid-19: a retrospective cohort study. medRxiv. 2021.

Zhang Y, Xie X, Yeganeh PN, Lee D-J, Valle-Garcia D, Meza Sosa K, Junqueira C, Su J, Luo H, Hide W, Lieberman J. Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown. PNAS. 2021; 118:e2022830118.

Sengupta S, Das S, Crespo A, Miller B, Sharma B, Zhang S, Dries R, Huang H, Krajewski M, Debruyne DN, Soriana L, Cohen MA, Versteeg R, et. al. Cell lineage as a predictor of immune response in neuroblastoma. BioRxiv. 2021.

Zhang Z, Zhang Y, Lieberman J. Lighting a fire: Can we harness pyroptosis to ignite antitumor immunity? Cancer Immunol Res. 2021 Jan; 9:2-7.

2020

Zhang Z, Lieberman J. Lighting a fire on the reef. Sci Immunol. 2020 Dec; 5(54):eabf0905.

Rosenblum D, Gutkin A, Kedmi R, Ramishetti S, Veiga N, Jacobi AM, Schubert MS, Friedmann-Morvinski D, Cohen ZR, Behlke MA, Lieberman J, Peer D. CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy. Sci Adv. 2020 Nov; 6(47): eabc9450.

Shi M, Wang L, Fontana P, Vora S, Zhang Y, Fu T-M, Lieberman J, Wu H. SARS-CoV-2 Nsp1 suppresses host but not viral translation through a bipartite mechanism. bioRxiv. 2020 Sep.

Hojo-Souza NS, de Azevedo PO, de Castro JT, Teixeira-Carvalho A, Lieberman J, Junqueira C, Gazzinelli RT. Contributions of IFN-γ and granulysin to the clearance of Plasmodium yoelii blood stage. PLoS Pathog. 2020 Sep; 16:e1008840.

Table 1

Crespo A, Mulik S, Dotiwala F et al. Decidual NK Cells Transfer Granulysin to Selectively Kill Bacteria in Trophoblasts. Cell. 2020 Sep; 182:1125-39.

Jun H, Liu X, Xia S et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol. 2020 Jul; 21:736.

Huang L, Deighan P, Jin J et al. Tombusvirus p19 Captures RNase III-Cleaved Double-Stranded RNAs Formed by Overlapping Sense and Antisense Transcripts in Escherichia coli. mBio. 2020 Jun; 11:e00485-20.

Liu X, Lieberman J. Knocking 'em Dead: Pore-Forming Proteins in Immune Defense. Annu Rev Immunol. 2020 Apr; 38:455-485.

Zhang Z, Zhang Y, Xia S et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020 Mar; 579:415.

2019

Lieberman J, Wu H, Kagan J. Gasdermin D activity in inflammation and host defense. Sci Immunol. 2019 Sep; 4: eaav1447.

Huang L, Deighan P, Jin J et al. Tombusvirus p19 captures RNase III-cleaved double-stranded RNAs formed by overlapping sense and antisense transcripts in E. coli. bioRxiv. 2019 Jun; 11:e00485.

Dotiwala F, Lieberman J. Granulysin: killer lymphocyte safeguard against microbes. Curr Opin Immmunol. 2019 May; 60:19.

Vu LT, Peng B, Zhang DX et al. Tumor-secreted extracellular vesicles promote the activation of cancer-associated fibroblasts via the transfer of microRNA-125b. J Extracell Vesicles. 2019 Apr; 8:1599680.

Supplementary material

2018

Radiana T. Trifonova*†, Brooke Bollman, Natasha S. Barteneva and Judy Lieberman*. Myeloid Cells in Intact Human Cervical Explants Capture HIV and Can Transmit It to CD4 T Cells. Frontiers in Immunology. 2018 Nov; 9:2719.

Lieberman J. Unveiling the RNA World. New Engl J Med. 2018 Sep; 379:1278-80.

Junqueira C, Barbosa CRR, Costa PAC, Teixeira-Carvalho A, Castro G, Sen Santara S, Barbosa RP, Dotiwala F, Pereira B, Antonelli LR, Lieberman J, Gazzinelli RT. Cytotoxic CD8+ T cells recognize and kill Plasmodium vivax-infected reticulocytes. Nat Med. 2018 Sep; 24:1330-6.

Hu JJ, Liu X, Zhao J,Xia S, Runa J, Luo X, Kim J, Lieberman J, Wu H. Identification of pyroptosis inhibitors that target a reactive cysteine in gasdermin D. bioRxiv. 2018 Jul; doi.org/10.1101/365908.

Meyer SE, Muench DE, Rogers AM, Newkold TJ, Orr E, O’Brien E, Perentesis JP, Doench JG, Lal A, Morris PJ, Thomas CJ, Lieberman J, McGlinn E, Aronow BJ, Salomonis N, Grimes HL. miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential. J Exp Med. 2018, 215, 2115-36.

Doan M, Vorobjev I, Rees P, Filby A, Wolkenhauer O, Goldfeld AE, Lieberman J, Barteneva N, Carpenter AE, Hennig H. Diagnostic Potential of Imaging Flow Cytometry. Trends Biotechnol. 2018 Jul; 36:649-52.

Liu X, Fu R, Pan Y, Meza-Sosa K, Zhang Z, Lieberman J. PNPT1 release from mitochondria during apoptosis triggers decay of poly(A) RNAs. Cell. 2018 Jun; 174:187-201.

Ruan J, Xia S, Liu X, Lieberman J, Wu H. Cryo-EM structure of the gasdermin A3 membrane pore. Nature. 2018 May; 557:62-7.

Clayton KL, Collins DR, Lengieza J, Ghebremichael M, Dotiwala F, Lieberman J, Walker BD. Resistance of HIV-infected macrophages to CD8(+) T lymphocyte-mediatedkilling drives activation of the immune system. Nat Immunol. 2018 May; 19:475-86.

Lieberman J. Tapping the RNA world for therapeutics. Nat Struct Mol Biol. 2018 May; 25:357-64.

Kedmi R, Veiga N, Ramishetti S, Goldsmith M, Rosenblum D, Dammes N, Hazan-Halevy I, Nahary L, Leviatan-Ben-Arye S, Harlev M, Behlke M, Benhar I, Lieberman J, Peer D. A modular platform for targeted RNAi therapeutics. Nat Nanotechnol. 2018 Mar; 13:214-9.

2017

Chan S, Sridhar P, Kirchner R, Lock YJ, Herbert Z, Buonamici S, Smith P, Lieberman J, Petrocca F. Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival. Mol Cancer Ther. 2017 Dec; 16:2849-61.

Sula Karreci E, Eskandari SK, Dotiwala F, Routray SK, Kurdi AT, Assaker JP, Luckyanchykov P, Mihali AB, Maarouf O, Borges TJ, Alkhudhayri A, Patel KR, Radwan A, Ghobrial I, McGrath M, Chandraker A, Riella LV, Elyaman W, Abdi R, Lieberman J, Azzi J. Human regulatory T cells undergo self-inflicted damage via granzyme pathways upon activation. JCI Insight. 2017 Nov; 2:(21). pii: 91599.

Dotiwala F, Sen Santara S, Binker-Cosen AA, Li B, Chandrasekaran S, Lieberman J. Granzyme B Disrupts Central Metabolism and Protein Synthesis in Bacteria to Promote an Immune Cell Death Program. Cell. 2017 Nov; 171:1125-37.

Liu X, Lieberman J. A mechanistic understanding of pyroptosis: the fiery death triggered by invasive infection. Adv Immunol. 2017 Apr; 135:87-117.

Su S, Liao J, Liu J, Huang D, He C, Chen F, Yang L, Wi W. Chen J, Lin L, Zeng Y, Ouyang N, Cui X, Yao H, Su F, Huang JD, Lieberman J, Liu Q, Song E. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017 Apr; 27:461-82.

Deruaz M, Murooka TT, Ji S, Gavin MA, Vrbanac VD, Lieberman J, Tager AM, Mempel TR, Luster AD. Chemoattractant-mediated leukocyte trafficking enables HIV dissemination from the genital mucosa. JCI Insight. 2017 Apr; 2:88533.

Liu X, Lieberman J. How ICE lights the pyroptosis fire. Cell Death Differ. 2017 Feb; 24:197-9.

2016

Liu X, Zhang Z, Ruan J, Pan Y, Venkat GM, Wu H, Lieberman J. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016 Jul; 535:153-8.

Wheeler LA, Trifonova RT, Vrbanac V, Barteneva N, Liu X, Bollman B, Onofrey L, Mulik S, Ranjbar S, Luster AD, Tager AM, Lieberman J. TREX1 knockdown induces an interferon response to HIV that delays viral infection in humanized mice. Cell Rep. 2016 May;15: 1715-27.

Lieberman J. Cytotoxic lymphocytes. In: Ratcliffe MJH (Editor in Chief), Encyclopedia of Immunobiology. 2016 May; 3:363-73. Oxford: Academic Press.

Boulias K, Lieberman J, Greer EL. An epigenetic clock measures accelerated aging in treated HIV infection. Mol Cell. 2016 Apr; 62:153-5.

Kedersha N, Panas MD, Achorn CA, Lyons S, Tisdale S, Hickman T, Thomas M, Lieberman J, McInerney GM, Ivanov P, Anderson P. G3BP-Caprin1-USP10 complexes mediate stress granule condensation and associate with 40S subunits. J Cell Biol. 2016 Mar; 212:845-60.

Basu R, Whitlock BM, Husson J, Le Floc'h A, Jin W, Oyler-Yaniv A, Dotiwala F, Giannone G, Hivroz C, Biais N, Lieberman J, Kam LC, Huse M. Cytotoxic T cells use mechanical force to potentiate target cell killing. Cell. 2016 Mar; 165:100-10.

Dotiwala F, Mulik S, Polidoro RB, Ansara JA, Burleigh BA, Walch M, Gazzinelli RT, Lieberman J. Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites. Nature Medicine. 2016 Feb; 22:210-6.

Tan SM, Lieberman J. Capture and identification of miRNA targets by biotin pulldown and RNA-seq. Methods Mol Biol. 2016 Jan; 1358:211-28.

Perdigão-Henriques R, Petrocca F, Altschuler G, Thomas MP, Le MTN, Tan SM, Hide W, Lieberman J. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes. Oncogene. 2016 Jan; 35:158-72.

Weinstein S, Toker IA, Emmanuel R, Ramishetti S, Hazan-Halevy I, Rosenblum D, Goldsmith M, Abraham A, Benjamini O, Bairey O, Raanani P, Nagler A, Lieberman J, Peer D. Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies. PNAS. 2016 Jan; 113:E16-22.

2015

Gilboa-Geffen A, Hamar P, Le MT, Wheeler LA, Trifonova R, Petrocca F, Wittrup A, Lieberman J. Gene knockdown by EpCAM aptamer-siRNA chimeras suppresses epithelial breast cancers and their tumor-initiating cells. Mol Cancer Ther. 2015 Oct; 14:2279-91.

Wittrup A, Lieberman J. Knocking down disease: a progress report on siRNA therapeutics. Nat Rev Genet. 2015 Sep; 16:543-52.

Wittrup A, Ai A, Liu X, Hamar P, Trifonova R, Charisse K, Manoharan M, Kirchhausen T, Lieberman J. Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown. Nat Biotechnol. 2015 Aug; 33:870-6.

Navarro F, Lieberman J. miR-34 and p53: new insights into a complex functional relationship. PLoS One. 2015 Jul;1 0:e0132767.

Lieberman J. Manipulating the in vivo immune response by targeted gene knockdown. Curr Opin Immunol. 2015 Jul; 35:63-72.

Dotiwala F, Fellay I, Filgueira L, Martinvalet D, Lieberman J, Walch M. A high yield and cost-efficient expression system of human granzymes in mammalian cells. J Vis Exp. 2015 Jun; 100:e52911.

O'Day E, Lee MT, Imai S, Tan SM, Kirchner R, Arthanari H, Hofmann O, Wagner G, Lieberman J. An RNA-binding protein, Lin28, recognizes and remodels G-quartets in the miRNAs and mRNAs it regulates. J Biol Chem. 2015 Jun; 290:17909-22.

Thomas MP, LiuX, Whangbo J, McCrossan G, Sanborn KB, Basar E, Walch M, Lieberman J. Apoptosis triggers specific, rapid, and global mRNA decay with 3'uridylated intermediates degraded by DIS3L2. Cell Rep. 2015 May; 11:1079-89.

Sharei A, Trifonova R, Jhunjhunwala S, Hartoularos GC, Eyerman AT, Lytton-Jean A, Angin M, Sharma S, Poceviciute R, Mao S, Heimann M, Liu S, Talkar T, Khan O, Addo M, von Andrian UH, Anderson DG, Langer R, Lieberman J, Jensen K. Ex Vivo cytosolic delivery of functional macromolecules to immune cells. PLoS One. 2015 Apr; 10:e0118803.

Luo ML, Chang G, Chen CH, Hu H, Huang P, Zheng M, Yao Y, Wei S, Wulf G, Lieberman J, Zhen Zhou X, Song E, Lu KP. The Rab2A GTPase promotes breast cancer stem cells and tumorigenesis via Erk signaling activation. Cell Rep. 2015 Apr; 11:111-24.

Lieberman J, Sharp P. Harnessing RNA interference for therapy: the silent treatment. JAMA. 2015 Mar; 313:1207-8.

Hata A, Lieberman J. Dysregulation of microRNA biogenesis and gene silencing in cancer. Sci Signal. 2015 Mar; 8:re3.

Jacquemin G, Margiotta D, Kasahara A, Bassoy EY, Walch M, Thiery J, Lieberman J, Martinvalet D. Granzyme B-induced mitochondrial ROS are required for apoptosis. Cell Death Differ. 2015 May; 22:862-74.

2014

Ivanov P, O'Day E, Emara MM, Wagner G, Lieberman J, Anderson P. G-quadruplex structures contribute to the neuroprotective effects of angiogenin-induced tRNA fragments. PNAS. 2014 Dec 23;111:18201-6.

Le M, Hamar P, Guo C, Basar E, Perdigao-Henriques R, Balaj L, Lieberman J. miR-200-containing extracellular vesicles promote breast cancer cell metastasis. J Clin Invest. 2014 Dec;124:5109-28.

Tan S, Kirchner R, Jin J, Hofmann O, McReynolds L, Hide W, Lieberman J. Sequencing of captive target transcripts identifies the network of regulated genes and functions of primate-specific miR-522. Cell Rep. 2014 Aug 21;8:1225-39.

Tay Y, Tan SM, Karreth F, Lieberman J, Pandolfi PP. Characterization of dual PTEN and p53-targeting microRNAs identifies miR-638/Dnm2 as a two-hit oncogenic locus. Cell Rep. 2014 Aug 7;8:714-22.

Luo M-L, Gong C, Chen C-H, Lee DY, Hu H, Huang P, Yao Y, Guo W, Reinhardt F, Wulf G, Lieberman J, Zhou XZ, Song E, Lu KP. Prolyl isomerase Pin1 acts downstream of miR-200 to promote cancer stem-like cell traits in breast cancer. Cancer Res. 2014 Jul 1;74:3603-16.

Walch M, Dotiwala F, Mulik S, Thiery J, Kirchhausen T, Clayberger C, Krensky A, Martinvalet D, Lieberman J. Cytotoxic cells kill intracellular bacteria through granulysin-mediated delivery of granzymes. Cell. 2014 Jun 5;157:1309-23.

Thomas MP, Whangbo J, McCrossan G, Deutsch A, Martinod K, Walch N, Lieberman J. Leukocyte protease binding to nucleic acids promotes nuclear localization and cleavage of nuclear binding proteins. J Immunol. 2014 Jun 1;192:5390-7.

Trifonova RT, Lieberman J*, van Baarle D*. Distribution of immune cells in the human cervix and implications for HIV transmission. Am J Reprod Immunol. 2014 Mar;71:252-64.

Thiery J, Lieberman J. Perforin - A Key Pore-forming Protein for Immune Control of Viruses and Cancer. Chapter in "Pore formation by MACPF/CDC proteins - agents of defense, attack and invasion," Anderluh G and Gilbert R, eds. Springer, Dordrecht. Subcell Biochem. 2014;80:197-220.

2013

Huang L, Lieberman J. Production of highly potent recombinant siRNAs in Escherichia coli. Nat Protoc. 2013 Dec;8:2325-36.

Tuli A, Thiery J, James AM, Michelet X, Sharma M, Garg S, Sanborn KB, Orange JS, Lieberman J, Brenner MB. Arf-like GTPase Arl8b regulates lytic granule polarization and natural killer cell-mediated cytotoxicity. Mol Biol Cell. 2013 Dec;24:3721-35.

Petrocca F, Altschuler G, Tan SM, Mendillo ML, Yan H, Jerry DJ, Kung Al, Hide W, Ince TA, Lieberman J. A Genome-wide siRNA screen identifies proteasome addiction as a vulneratility of basal-like triple-negative breast cancer cells. Cancer Cell. 2013 Aug 12;24(2):182-96.

Wheeler LA, Vrbanac V, Trifonova R, Brehm M, Gilboa-Geffen A, Tanno S, Greiner DL, Luster AD, Tager AM, Lieberman J. Durable knockdown and protection from HIV transmission in humanized mice treated with gel-formulated CD4 aptamer-siRNA chimeras. Mol Ther. 2013 Jul;21(7):1378-89.

Huang L, Jin J, Deighan P, Kiner E, McReynolds L, Lieberman J. Efficient and specific gene knockdown by small interfering RNAs produced in bacteria. Nat Biotechnol. 2013 Apr;31(4):350-6.

Lee MN, Roy M, Ong S-E, Mertins P, Villani A-C, Li W, Dotiwala F, Sen J, Doench JG, Orzalli MH, Kramnik I, Knipe DM, Lieberman J, Carr SA, Hacohen N. Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach. Nat Immunol. 2013 Feb;14(2):179-85.

Lieberman J. Noncoding RNAs and cancer: knockout punch for cancer. Cell. 2013 Mar 28;153(1):9-10.

Lieberman J, Sarnow P. Micromanaging hepatitis C virus. N Eng J Med. 2013 May 2;368(18):1741-3.

Thomas MP, Lieberman J. Live or let die: post-transcriptional gene regulation in cell stress and cell death. Immunol Rev. 2013 May;253(1):237-52.

Lieberman J. "Cell-mediated cytoxicity," Chapter 37 in Paul WE, Fundamental Immunology, 7th edition, Lippincott, Williams & Wilkins, 2013;891-909.

2012

Rajani DK, Walch M, Martinvalet D, Thomas MP, Lieberman J. Alterations in RNA processing during immune-mediated programmed cell death. PNAS. 2012;109(22):8688-93.

Yao Y-D, Sun T-M, Huang S-Y, Dou S, Lin L, Chen J-N, Ruan J-B, Mao C-Q, Yu F-Y, Zeng M-S, Zang J-Y, Liu Q, Su F-X, Zhang P, Lieberman J, Wang J, Song E. Targeted delivery of PLK1-siRNA by ScFv suppresses Her2+ breast cancer growth and metastasis. Sci Transl Med. 2012;4(130):130ra48.

Kang H, Davis-Dusenbery BN, Nguyen PH, Lal A, Lieberman J, Van Aeist L, Lagna G, Hata A. Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating microRNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteins. J Biol Chem. 2012;287(6):3976-86.

Yan N, Lieberman J. SAMHD1 does it again, now in resting T cells. Nat Med. 2012;18(11):1611-2.